| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Zymer Prodexim Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 752 | 744 | 732 | 718 | 704 | 691 | 676 | 678 | 676 | 672 |
| Current Assets | 9.098 | 9.006 | 8.853 | 8.691 | 8.522 | 8.361 | 8.175 | 8.201 | 8.176 | 8.130 |
| Inventories | 8.521 | 8.435 | 8.292 | 8.140 | 7.982 | 7.831 | 7.657 | 7.681 | 7.658 | 7.615 |
| Receivables | 570 | 564 | 554 | 544 | 534 | 523 | 512 | 513 | 512 | 509 |
| Cash | 7 | 7 | 7 | 7 | 7 | 7 | 6 | 6 | 6 | 6 |
| Shareholders Funds | 328 | 325 | 319 | 313 | 307 | 301 | 295 | 296 | 295 | 293 |
| Social Capital | 562 | 557 | 547 | 537 | 527 | 517 | 505 | 507 | 505 | 503 |
| Debts | 9.800 | 9.700 | 9.536 | 9.361 | 9.180 | 9.006 | 8.806 | 8.833 | 8.806 | 8.757 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4771 - 4771" | |||||||||
| CAEN Financial Year |
4771
|
|||||||||
Comments - Zymer Prodexim Srl